Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. The company is headquartered in Seattle, Washington and currently employs 1,121 full-time employees. The company went IPO on 2014-07-18. The firm operates in two segments, namely, Subscription Business and Other Business. The Subscription Business segment includes subscription fees related to the Company's direct-to-consumer products. The Other Business segment comprises other product offerings that generally have a business-to-business relationship and a different margin profile than its subscription segment, including writing policies on behalf of third parties and other products and software solutions. The company offers Trupanion, software that is designed to communicate directly with veterinary hospital's practice management software. The company provides Powered by Trupanion pet insurance product offerings marketed by third parties and marketed under the brand names Furkin and PHI Direct in Canada, and a Trupanion branded product in Germany and Switzerland.
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for TRUP. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: TRUP is a Buy candidate.
TRUP stock price ended at $25.81 on 火曜日, after rising 3.78%
On the latest trading day Jul 28, 2026, the stock price of TRUP rose by 3.78%, climbing from $25.08 to $25.81. Throughout the session, the stock experienced a volatility of 3.55%, with prices fluctuating between a daily low of $25.08 and a high of $25.97. Alongside this price increase, trading volume also rose by 236.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 101.5K shares were traded, amounting to a market value of approximately $1.1B.